The Vanguard Group, Inc. Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. has released a disclosure statement under the Irish Takeover Panel rules regarding its position in Mural Oncology plc. As of November 21, 2025, Vanguard holds 289,211 $0.01 ordinary shares, representing a 1.67% interest in the company. This disclosure is in compliance with Rule 8.3 of the Irish Takeover Panel Act, 1997.

Vanguard's latest disclosure does not include details of any short positions or cash-settled derivatives. Additionally, there are no agreements or understandings concerning voting rights or the future acquisition or disposal of relevant securities. No indemnities or other dealing arrangements have been entered into.

The report confirms that no supplemental Form 8 is attached, indicating no further detailed information is necessary at this time.